STOCK TITAN

Elevance Health, Inc. - ELV STOCK NEWS

Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.

Elevance Health, Inc. (symbol: ELV) is a prominent American health insurance provider, formerly known as Anthem, Inc. until June 2022. As one of the leading health insurers in the United States, Elevance Health delivers medical benefits to approximately 47 million members as of December 2023. The company’s core business revolves around offering a wide range of coverage plans, including employer, individual, and government-sponsored options.

One distinctive feature of Elevance Health is its status as the largest single provider of Blue Cross Blue Shield branded coverage. As the licensee for the Blue Cross Blue Shield Association in 14 states, the company serves a significant portion of the U.S. population. Elevance Health has successfully expanded its offerings through strategic acquisitions, such as the purchase of Amerigroup in 2012 and MMM in 2021. These acquisitions enable the company to broaden its reach and better serve populations enrolled in government-sponsored programs like Medicaid and Medicare Advantage plans.

Elevance Health is committed to improving healthcare accessibility and affordability. The company consistently works on enhancing its services and products to meet the evolving needs of its members. Financially, Elevance Health has maintained a strong position, reflecting robust performance and growth potential.

Recent achievements include the expansion of digital health initiatives and partnerships with healthcare providers to offer more integrated and comprehensive care solutions. With its extensive network and innovative approach, Elevance Health continues to make significant strides in the healthcare industry.

Stay updated with the latest news and developments related to Elevance Health to understand its impact and future direction in the health insurance market.

Rhea-AI Summary

Elevance Health (NYSE: ELV) reported its Q2 2024 results, with operating revenue of $43.2 billion and adjusted operating gain of $2.8 billion. The company's diluted EPS increased by 26% to $9.85, while adjusted diluted EPS rose 12% to $10.12. Elevance Health declared a Q3 2024 dividend of $1.63 per share.

The benefit expense ratio improved to 86.3%, while the operating expense ratio increased to 11.7%. The company maintains its full-year outlook, expecting GAAP net income per diluted share to be at least $34.05 and adjusted diluted net income per share to be at least $37.20 in 2024.

Elevance Health's Health Benefits segment saw a 2% decrease in operating revenue, while Carelon segment's operating revenue increased by 10% compared to the prior year quarter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.82%
Tags
-
News
Rhea-AI Summary

Elevance Health has released its annual Impact Report, showcasing its transformation from a traditional health insurance company to a comprehensive healthcare services provider. Key achievements include receiving the Health Equity Accreditation Plus from the National Committee for Quality Assurance, supporting Medicaid eligibility renewals, and expanding Carelon. The company was recognized among America’s top 50 most community-minded companies and featured in JUST Capital’s JUST 100. The report emphasizes Elevance Health’s efforts to cater to the unique needs of each health plan member, assess and address health drivers, form community partnerships, and utilize data-driven insights to enhance and personalize healthcare services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
-
Rhea-AI Summary

Elevance Health (NYSE: ELV) will announce its second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. EDT. A conference call to discuss these results and the company's outlook will follow at 8:30 a.m. EDT. The domestic access number for the call is 888-947-9963 with the access code 3972058, and for international participants, the number is 312-470-0178 with the same access code. A replay of the call will be available domestically at 800-391-9851 and internationally at 203-369-3268 from 11:30 a.m. EDT on July 17 until August 17, 2024. Additionally, the call will be accessible via a live webcast on the Elevance Health website under the 'Investors' section.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
conference call earnings
Rhea-AI Summary

Elevance Health (NYSE: ELV) will present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. EDT. Senior management will deliver the presentation, which will be webcast live on the company's investor relations website. A replay of the presentation will be available for 90 days following the event. Interested individuals are advised to visit the website early to download any necessary software. This presentation will reflect Elevance Health's recent SEC filings, including their Annual Report on Form 10-K for the year ending December 31, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.14%
Tags
none
-
Rhea-AI Summary

Elevance Health (NYSE: ELV) announced its participation in Bernstein's 40th Annual Strategic Decisions Conference in New York City on May 31 at 9:00 a.m. EDT.

Senior management will present critical company updates. Interested parties can access a live webcast through Elevance Health's investor site.

A replay will be available for 90 days post-presentation.

Listeners are advised to review Elevance Health's recent SEC filings, including the 2023 Annual Report on Form 10-K.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
none
-
Rhea-AI Summary
Elevance Health, Inc. (ELV) reported first quarter 2024 results with operating revenue of $42.3 billion, up 0.9% from 1Q 2023. Diluted EPS increased by 15.5% to $9.59 and adjusted diluted EPS by 12.5% to $10.64. FY 2024 EPS guidance raised to over $34.05 and adjusted EPS to over $37.20. A strategic partnership with Clayton, Dubilier & Rice was announced to advance primary care and physician enablement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.19%
Tags
Rhea-AI Summary
Elevance Health and Clayton, Dubilier & Rice sign a strategic partnership agreement to enhance primary care delivery, focusing on innovation, patient experience, and health outcomes. The collaboration aims to leverage the strengths of three care provider entities to improve healthcare across the United States.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
partnership
-
Rhea-AI Summary
Elevance Health (NYSE: ELV) will announce its first quarter 2024 financial results on April 18, 2024, with a conference call scheduled for the same day. Investors can access the call through various means, including phone numbers and a live webcast on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.46%
Tags
-
Rhea-AI Summary
Elevance Health (NYSE: ELV) acquires Paragon Healthcare, enhancing its capabilities in multi-site infusion services and specialty pharmacy. Paragon Healthcare, a leading provider of infusion services, operates ambulatory infusion centers, home infusion pharmacies, and specialty pharmacy services across eight states, serving over 35,000 patients. The acquisition aims to provide affordable, convenient access to specialty medications for patients with chronic illnesses, ultimately improving medication adherence, lowering costs, and supporting whole health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
Rhea-AI Summary
Performant Financial Corporation (PFMT) appoints Dr. Shantanu Agrawal, M.D. to its Board of Directors, bringing expertise in healthcare policy and payment integrity. Dr. Agrawal's background includes executive roles at Elevance Health and CMS, shaping payment integrity programs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
management

FAQ

What does Elevance Health, Inc. do?

Elevance Health, Inc. is an American health insurance provider offering employer, individual, and government-sponsored coverage plans.

What was Elevance Health, Inc. previously known as?

Prior to June 2022, Elevance Health, Inc. was known as Anthem, Inc.

How many members does Elevance Health serve?

As of December 2023, Elevance Health provides medical benefits to 47 million members.

What makes Elevance Health unique among its peers?

Elevance Health is the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states.

What major acquisitions has Elevance Health completed?

Elevance Health acquired Amerigroup in 2012 and MMM in 2021, expanding its reach in government-sponsored programs like Medicaid and Medicare Advantage.

What types of health plans does Elevance Health offer?

Elevance Health offers employer, individual, and government-sponsored coverage plans, including Medicaid and Medicare Advantage.

How does Elevance Health contribute to improving healthcare?

Elevance Health works on enhancing service accessibility and affordability, incorporating digital health initiatives, and forming partnerships with healthcare providers.

What is the financial condition of Elevance Health?

Elevance Health has maintained a strong financial position, showing robust performance and growth potential.

What recent initiatives has Elevance Health undertaken?

Recent initiatives include the expansion of digital health services and more integrated care solutions through partnerships with healthcare providers.

How can I stay updated on Elevance Health's latest news?

Stay informed by following the latest news and updates about Elevance Health to understand its impact and direction in the health insurance market.

Elevance Health, Inc.

NYSE:ELV

ELV Rankings

ELV Stock Data

116.84B
231.89M
0.2%
91.37%
0.98%
Direct Health and Medical Insurance Carriers
Finance and Insurance
Link
United States of America
INDIANAPOLIS